ArticleCell reports. Medicine2024

CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa.

Nicholas D Nolan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.